Atterx
2 known investors
Find your way into Atterx
Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.
Founders & leadership
JM
James MillarinChief Executive Officer
Investors · 2
In the news
Frequently asked questions
- What does Atterx do?
- Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.
- Who are Atterx's investors?
- Atterx's investors include Michigan Rise, Wisconsin Investment Partners.